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Abstract
Two general practitioners (GPs) with SARS-CoV-2 infection provided in-person patient care
to patients of their joint medical practice before and after symptom onset, up until SARS-
CoV-2 laboratory confirmation. Through active contact tracing, the local public health
authorities recruited the cohort of patients that had contact with either GP in their putative
infectious period. In this cohort of patient contacts, we assess the frequency and determinants
of SARS-CoV-2-transmission from GPs to patients. We calculated incidence rate ratios (IRR)
to explore the type of contact as an explanatory variable for COVID-19 cases. Among the
cohort of 83 patient contacts, we identified 22 (27%) COVID-19 cases including 17 (21%)
possible, three (4%) probable and two (2%) confirmed cases. All 22 cases had contact with
a GP when the GP did not wear a mask, and/or when contact was ≥10 min. Importantly,
patients who had contact <10 min with a GP wearing a facemask were at reduced risk (IRR
0.21; 95% CI 0.01–0.99) of COVID-19. This outbreak investigation adds to the body of evi-
dence in supporting current guidelines on measures at preventing the transmission of
SARS-CoV-2 in an outpatient setting.
Background
In Germany, the first case of COVID-19 was confirmed on 27 January 2020 [1]. This was
followed by several introductions and clusters of cases of COVID-19. On 27 February,
Germany reported a total of 26 cases [2]. By 3 March 2020, 196 cases were reported, of
which the majority (n = 101) belonged to a large cluster in North-Rhine Westphalia or were
linked to importation from high-risk areas (n = 35, from Italy, China, Iran) [3]. Three days
later, on 6 March 2020, a total of 639 confirmed COVID-19 cases were reported in
Germany [4]. Extensive contact tracing by the responsible health authorities was ongoing.
In this field report, we report about the seventh case of COVID-19 and the associated clus-
ter of contacts and cases that was notified to a local public health authority in Germany (dis-
trict population of >500 000), on 6 March 2020, in the context of a GP practice. In addition to
contact tracing activities, we conducted an outbreak investigation to assess the likelihood of
transmission in a GP setting by means of a retrospective cohort study of patient contacts.
Epidemiology of the incident
Two GPs, working in their joint medical practice, had fallen ill with COVID-19 on 29
February and 4 March 2020, respectively. Both GPs had been attending to patients shortly
before and after the onset of respiratory symptoms, until laboratory confirmation of
SARS-CoV-2 infection on 6 March 2020 (Fig. 1). Of note, because of the limited number
of cases of COVID-19 in the area at that time, exposure to SARS-CoV-2 outside of the GP
practice was deemed unlikely.
Response and outbreak investigation
Through active contact tracing as by local guidelines, in line with national and international
guidelines [5, 6], close contacts were identified, interviewed by phone, and ordered quarantine
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and PCR-testing, if applicable. For the purpose of the analytical
study (outbreak investigation), the local public health authorities
recruited the cohort of patients that had contact with either GP in
their putative infectious period (starting 2 days before and ending
10 days after the date of symptom onset). The cohort of patients
that was exposed to SARS-CoV-2 during their GP visit provided
the unique opportunity to investigate the likelihood of transmis-
sion in a GP setting. Therefore, and in accordance with national
contact tracing guidelines [5], we included patients in our cohort
who were exposed to either GP 2 days before their respective date
of symptom onset until laboratory confirmation of SARS-CoV-2
infection of the GP. Thus, the study period included all valid
patient contacts from 27 February to 5 March 2020. The GPs
were self-isolating from 6 March 2020 onwards. One GP’s clinical
situation deteriorated and s/he was hospitalised for a week, with
pneumonia showing infiltrates on the left and right lungs. Both
GPs made a full recovery. Close contacts of either GP were
ordered a 14-day home quarantine. Quarantine included active
daily monitoring of COVID-19 symptoms and testing for
SARS-CoV-2 in the event of symptom onset and/or at the end
of the quarantine period. The full referent period can therefore
be defined as the 27 February 2020 (2 days before the symptom
onset of the first GP) up to and including 19 March 2020 (last
day of quarantine). Work-related contacts included six practice
assistants; all reported distant contact, tested negative for
SARS-CoV-2 and were not considered part of the cohort.
In addition to routine contact tracing phone calls, we inter-
viewed all patient contacts by phone at the end of their putative
incubation period (14 days after exposure) and again 4 weeks
later, using a standardised questionnaire. We collected informa-
tion on demographics, medical and travel history. In addition,
for each GP visit, the (medical) purpose, duration and type of
contact with the GP were extracted, including which GP was
seen, the distance to the GP, if the patient was physically exam-
ined and whether or not the GP wore a medical facemask. At
the time, wearing a facemask by GPs was not yet recommended
as a standard infection prevention and control measure for all
situations of direct contact to all patients (regardless of infection
status) in Germany [7].
We collected information on potential symptom onset in the 14
days after risk contact with the GP, including the type and timing
of general and COVID-19-associated symptoms [8, 9]. New onset
was defined as a symptom that started the day after the risk contact
up until 14 days after the GP visit. COVID-19-compatible symp-
toms were separated into respiratory and non-respiratory symp-
toms/clinical diagnoses. Respiratory symptoms/clinical diagnoses
included cough, sore throat, common-cold (runny nose), shortness
of breath and/or pneumoniae. Non-respiratory symptoms included
fever, anosmia (loss of the sense of smell), ageusia (loss of the sense
of taste), dysgeusia (distortion of the sense of taste), headache,
back-pain, muscle ache, joint-pain, loss of appetite and/or weight,
nausea, vomiting, diarrhoea, conjunctivitis, skin rash, swollen
lymph nodes and/or apathy.
Case definitions were based on self-reported symptoms and
laboratory criteria. Possible cases reported onset of at least two
COVID-19-compatible symptoms. Probable cases met the criteria
for a possible case, but also had pneumonia, anosmia, ageusia or
dysgeusia. Confirmed cases tested positive for SARS-COV-2,
regardless of symptoms (i.e. national COVID-19 case definition).
We used negative binomial regression to calculate incidence
rate ratios (IRR with 95% confidence intervals (95% CI)) to
explore the risk (frequency and determinants) of SARS-CoV-2
transmission from GPs to patients using the MASS and fmsb
packages in R Version 3.6.3.
We conducted this outbreak investigation as part of the official
tasks of the local public health authorities of the respective district
Fig. 1. Date of symptom onset of possible, probable and confirmed COVID-19 cases within the cohort of patient contacts of two SARS-CoV-2-positive GPs in a
medical practice in Germany, February–March 2020. Symptom onset of either GP, the days they attended to patients, and closure of the GP medical practice
are marked by blue (GPX), pink (GPY) and black arrows, respectively.
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supported by the Robert Koch Institute upon official request in
accordance to §4 of the German Protection against Infection
Act. Therefore, this investigation was exempt from additional
institutional review.
Results and discussion
We reached 91 (70%) of 131 patient contacts as traced by the local
health authority. The 40 patient contacts who could not be
reached had a median age of 32 (IQR 28–43) years, and 21
(53%) were female. Of the 91 reached, two contacts did not
meet our inclusion criteria – they were not exposed to or were
exposed outside the infectious period of either GP – and six did
not consent. Thus, 83 (91%) of 91 were included in the cohort
study.
The median age was 45 (IQR 7–87]) years, 56 (68%) were
female. There were 25 (30%) current smokers (tobacco) and 54
(65%) reported underlying conditions. Fifteen people reported
travelling in the 2 weeks before visiting their GP; no one travelled
to areas classified as risk areas (international) or particularly
affected areas (in Germany). Some patients visited their GPs
more than once during the infectious period of the GPs. We
therefore recorded 89 contact-events in our study (GPX n = 43;
GPY n = 46). Patients spent a median of 10 min (IQR 10–20)
with their GP. The GPs wore a medical facemask during 31
(35%) of 89 contact-events, more often during physical examin-
ation (25/56; 45%) compared to no physical examination (6/32;
19%; Fisher’s exact P = 0.046).
In total, 28 participants (33.7%) reported onset of
COVID-19-associated symptoms after exposure to either GP, 22
(26.5%) reported respiratory symptoms including fever, 21
(25.3%) reported respiratory symptoms, irrespective of fever.
Sore throat (n = 17; 61%), cough (n = 10; 36%), common cold
(n = 10; 36%), headache (n = 9; 32%) and apathy (n = 7; 25%)
were the most frequently reported symptoms (Fig. 2). We
identified 22 (27%) COVID-19 cases, including 17 (21%) possible,
three (4%) probable and two (2%) confirmed cases (Fig. 1 and
Table 1).
No single type of contact was significantly associated with the
risk of getting COVID-19 (Table 2); however, the trends indicated
that contact with GPX, contact in the pre-symptomatic phase
(data included for GPX only, as GPY has not seen any patient
in their pre-symptomatic phase), and contact ≥10 min increased
the risk, while contact with a GP who was wearing a facemask
decreased the risk (Table 2). All 22 identified COVID-19 cases
had contact with a GP when the GP did not wear a mask, and/
or when contact was ≥10 min. Importantly, contact <10 min
with a GP wearing a facemask was significantly associated with
a reduced risk (IRR 0.21; 95% CI 0.01–0.99) of COVID-19.
When assessing the risk using a cumulative score (1 point for
each: duration ≥10 min; distance <1 m and/or physical examin-
ation; contact without a facemask or contact ≥10 min with face-
mask), trends indicated that increased exposure increased the
risk of COVID-19 (IRR per point 1.23; 95% CI 0.76–2.15).
The results should be interpreted considering the following
limitations. First, and due to the observational nature of our
study, our case definitions are subject to potential misclassifica-
tion. Our case definition for possible cases is very sensitive and
includes symptoms that could also have been caused by patho-
gens other than SARS-CoV-2, e.g. seasonal influenza, which
were still circulating at the time of the outbreak investigation.
Conversely, the definition of confirmed cases relied on the
availability of PCR test results. Although the majority of
exposed patients (64/83) were tested, it is possible that asymp-
tomatic cases or cases developing infection after the test were
missed. Second, we cannot exclude that individual cases
acquired their SARS-CoV-2 infection through a different
exposure (i.e. not in the GP practice). However, as community
transmission in the district was still very limited at the time [3,
4], we consider this possibility unlikely. Third, we could trace
70%, but not all, of the listed GP contacts; this is a finding
Fig. 2. Percentage of self-reported onset of COVID-19-associated symptoms after contact with either GP, presented as a percentage of the full cohort, as recalled by
the 28/83 study participants.
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on its own. However, it does potentially introduce bias to the
results, because we do not know if the contacts who were not
reached had a specific profile irrespective of age or sex or
whether the non-response was associated with being a case.
Last, because of the limited cohort size, not all potentially con-
founding factors, such as patient characteristics (e.g. under-
lying illness) combined with possible differences in patient
contact with GPX or GPY could be considered in the statistical
analysis.
Conclusion
In conclusion, the use of facemasks for GPs and short consult-
ation times helped limiting the spread of SARS-CoV-2 from
GPs to their patients. Should a GP or other healthcare workers
outside of a hospital setting with COVID-19 be shedding
SARS-CoV-2 at the peak of infectiousness (i.e. shortly before
or after symptom onset) then these types of infection preven-
tion and control measures may prevent transmission to
Table 1. Summary of characteristics of the five confirmed and probable COVID-19 cases within the cohort of patient contacts of two SARS-CoV-2-positive GPs in a GP
practice in Germany, 2020
Case 1 Case 2 Case 3 Case 4 Case 5
Case classification Confirmed Confirmed Probable Probable Probable
Age (years) 21 41 24 49 83
Sex Female Female Female Female Female
Incubation period (days) 3 14 3 1 5




GP visited X X Y Y Y
Time with GP (minutes) 10 10 13 12 5
Distance to GP (meter) <1 <1 1–2 <1 <1
Close contacta Close Close Close Close Close
Physical examination by GP Yes No Yes Yes Yes
GP wore a face mask No No Yes Yes No
Risk contact scoreb 2 2 2 2 2
aCombination of distance <1 m and/or physical examination/blood drawn/injection.
bRisk contact score (scale 0–3), one point for each: duration (1 point if ≥10min), distance (1 point for <1 m and/or physical examination), GP with facemask (1 point for contact without a
facemask, or contact ≥10min with a facemask).
Table 2. Incidence and incidence rate ratios (IRR) of COVID-19 cases (possible, probable and confirmed), by risk contact-event with SARS-CoV-2-positive general
practitioners (GP)
Type of risk contact Exposure
Total
(n = 89) %
No case
(n = 67) %
Case







GP GP Y 46 51.7 36 53.7 10 45.5 1 (ref) (ref) (ref)
GP X 43 48.3 31 46.3 12 54.5 1.28 0.55 3.04
Phase of infection of GPs Symptomatic 20 22.5 16 23.9 4 18.2 1 (ref) (ref) (ref)
Pre-symptomatic 69 77.5 51 76.1 18 81.8 1.30 0.49 4.51
Duration ≥10 min 70 78.7 52 77.6 18 81.8 1 (ref) (ref) (ref)
<10 min 18 20.2 15 22.4 3 13.6 0.65 0.15 1.91
Facemask worn by GP No facemask 53 59.6 39 58.2 14 63.6 1 (ref) (ref) (ref)
Facemask 31 34.8 24 35.8 7 31.8 0.85 0.32 2.05
Unknown 5 5.6 4 6.0 1 4.5 – – –
Duration and facemask
worn by GP combineda
Exposed (contact ≥10 min and/or
GP not wearing facemask)
75 84.3 53 79.1 22 100 1 (ref) (ref) (ref)
Unexposed (GP wore facemask
and <10 min contact)
14 15.7 14 20.9 0 0.0 0.21 0.01 0.99
Risk contact scoreb Per point (continuous) NA NA NA NA NA NA 1.23 0.76 2.15
aIRR calculated using Haldane-Anscombe correction.
bRisk contact score (scale 0–3), one point for each: duration (1 point if ≥10 min), distance (1 point for <1m and/or physical examination), GP with facemask (1 point for contact without a
facemask, or contact ≥10min with a facemask).
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susceptible patients. Our investigation lends support to current
guidelines from WHO and the ECDC, both recommending all
healthcare workers to continuously wear a medical facemask at
work especially in areas of community transmission [10–13].
Data
Detailed data are confidential and protected by German law.
Anonymised data are available from the corresponding author
upon reasonable request.
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